Current issues in immunomodulatory treatment of multiple sclerosis: A practical approach

Journal of Neurology

Volumn 253, Issue 1 SUPPL., 2006, Pages

  Stangel, Martin ^a   Gold, Ralf ^b   Gass, Achim ^c   Haas, Judith ^d   Jung, Stefan ^e   Elias, Wolfgang ^f   Zettl, Uwe K ^g  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c UNIVERSITY OF BASEL   (Switzerland)

^d MARTIN LUTHER KRANKENHAUS   (Germany)

^e SAARLAND UNIVERSITY   (Germany)

^f University Rostock ^*

^g UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BETA INTERFERON; CYCLOPHOSPHAMIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; MITOXANTRONE; NATALIZUMAB; STEROID;

AMENORRHEA; CARDIOTOXICITY; CONFERENCE PAPER; DIAGNOSTIC PROCEDURE; FETUS WASTAGE; FOLLOW UP; HUMAN; IMMUNOMODULATION; INFERTILITY; LOW BIRTH WEIGHT; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT CARE; PLASMAPHERESIS; PREGNANCY; PRIORITY JOURNAL; TREATMENT OUTCOME;

FEMALE; HUMANS; IMMUNOTHERAPY; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; PREGNANCY;

EID: 32544452724     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00415-006-1108-9     Document Type: Conference Paper

References (20)

1. Achiron A, Kishner I, Dolev M, Stern Y, Dulitzky M, Schiff E, Achiron R (2004) Effect of intravenous immunoglobulin treatment on pregnancy and post-partum related relapses in multiple sclerosis. J Neurol 251:1133-1137
2. Berger JR, Koralnik IJ (2005) Progressive multifocal leukencephalopathy and natalizumab - unforeseen consequences. N Engl J Med 353:414-416
3. Boskovic R, Wide R, Wolpin J, Bauer DJ, Koren G (2005) The reproductive effects of beta interferon therapy in pregnancy. A longitudinal cohort. Neurology 65:807-811
4. Bot JC, Barkhof F, Polman CH, Lycklama a Nijeholt GJ, De Groot V, Bergers E, Ader HJ, Castelijns JA (2004) Spinal cord abnormalities in recently diagnosed MS patients: added value of spinal MRI examination. Neurology 62:226-233
5. Dalton CM, Brex PA, Miszkiel KA, Fernando K, MacManus DG, Plant G, Thompson AJ, Miller DH (2003) New T2 lesions enable an earlier diagnosis of multiple sclerosis in clinically isolated syndromes. Ann Neurol 53:673-676
6. de Seze J, Chapelotte M, Delalande S, Ferriby D, Stojkovic T, Vermersch P (2004) Intravenous corticosteroids in the postpartum period for reduction of acute exacerbations in multiple sclerosis. Mult Scler 10:596-597
7. Freedman MS, Patry DG, Grand'Maison F, Myles ML, Paty DW, Selchen DH, Canadian MS Working Group (2004) Treatment optimization in mulitple sclerosis. Can J Neurol Sci 31:157-168
8. Gass A, Radü E-W, Filippi M, Kappos L (1999) MRI follow-up in multiple sclerosis. A guideline for quality assurance. RöFo 170:581-586
9. Jacobs LD, Beck RW, Simon JH, Kinkel RP, Brownscheidle CM, Murray TJ, Simonian NA, Slasor PJ, Sandrock AW, the CHAMPS study group (2001) Intramuscular interferon 1a therapy initiated during a first demyelinating event in Multiple Sclerosis. N Engl J Med 343:898-904
10. Keegan M, König F, McClelland R, Brück W, Morales Y, Bitsch A, Panitch H, Lassmann H, Weinshenker B, Rodriguez M, Parisi J, Lucchinetti CF (2005) Relationship between humoral pathological changes in multiple sclerosis and response to plasma exchange. Lancet 366:579-582
11. McDonald WI, Compston A, Edan G, Goodkin D, Hartung H-P, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BG, Wolinsky JS (2001) Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121-127
12. Multiple Sclerosis Therapy Consensus Group (2004) Escalating immunotherapy of multiple sclerosis - new aspects and practical application. J Neurol 251:1329-1339
13. Polman CH, Wolinsky JS, Reingold SC (2005) Multiple sclerosis diagnostic criteria: three years later. Mult Scler 11:5-12
14. 13a. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, Lublin FD, Metz LM, McFarland HF, O'Connor PW, Sandberg-Wollheim M, Thompson AJ, Weinshenker BG, Wolinsky JS (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald criteria". Ann Neurol 58:840-846
15. Reggio E, Nicoletti A, Fiorilla T, Politi G, Reggio A, Patti F (2005) The combination of cyclophosphamide and interferon beta as rescue therapy could be used to treat relapsing-remitting multiple sclerosis patients. Twenty-four month follow-up. J Neurol 252:1255-1261
16. Ruprecht K, Klinker E, Dintelmann T, Rieckmann P, Gold R (2004) Plasma exchange for severe optic neuritis. Treatment of 10 patients. Neurology 63:1081-1083
17. Sandberg-Wollheim M, Frank D, Goodwin TM, Giesser B, Lopez-Bresnahan M, Stam-Moraga M, Chang P, Francis GS (2005) Pregnancy outcomes during treatment with intreferon beta-1a in patients with multiple sclerosis. Neurology 65:802-806
18. Weinshenker BG, O'Brien PC, Petterson TM, Noseworthy J, Lucchinetti CF, Dodick DW, Pineda AA, Stevens LN, Rodriguez M (1999) A randomized trial of plasma exchange in acute central nervous system demyelinating disease. Ann Neurol 46:878-886
19. Wolinsky JS, PROMiSe Study Group (2003) The diagnosis of primary progressive multiple sclerosis. J Neurol Sci 206:145-152
20. Zettl UK, Tumani H (2005) Multiple sclerosis and cerebrospinal fluid. Blackwell, Oxford, UK